Paperpal Prime Logo

Personalized Medicine : Impact Factor & More

eISSN: 1744-828XpISSN: 1741-0541

Key Metrics

CiteScore
3.5
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Personalized Medicine

Personalized Medicine Journal Specifications

Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Personalized Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Personalized Medicine

The impact of the rise of the chatbots: transforming genetics clinical delivery and research.
  • 2 Jul 2026
  • Personalized medicine
Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.
  • 1 Jun 2026
  • Personalized medicine
Strengthening the evidence base for precision medicine through the utilization of real-world data and real-world evidence: a narrative review from the U.S. perspective.
  • 1 Jun 2026
  • Personalized medicine
In silico characterization of MC4R variants reveals insights into Setmelanotide pharmacogenomics and personalized medicine for obesity.
  • 1 Jun 2026
  • Personalized medicine
Association between microRNA 155 gene polymorphism and sporadic Parkinson's disease.
  • 1 Jun 2026
  • Personalized medicine
Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium.
  • 1 Jun 2026
  • Personalized medicine
The impact of the rise of the chatbots: transforming genetics clinical delivery and research.
  • 2 Jul 2026
  • Personalized medicine
Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.
  • 1 Jun 2026
  • Personalized medicine
Strengthening the evidence base for precision medicine through the utilization of real-world data and real-world evidence: a narrative review from the U.S. perspective.
  • 1 Jun 2026
  • Personalized medicine
In silico characterization of MC4R variants reveals insights into Setmelanotide pharmacogenomics and personalized medicine for obesity.
  • 1 Jun 2026
  • Personalized medicine
Association between microRNA 155 gene polymorphism and sporadic Parkinson's disease.
  • 1 Jun 2026
  • Personalized medicine
Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium.
  • 1 Jun 2026
  • Personalized medicine

FAQs on Personalized Medicine